/ healthcare / Haelium™ Piperidine

Haelium™ Piperidine

a deprotection reagent for peptide drug synthesis

  • high-purity and reactivity make it indispensable for the manufacturing of peptide-based therapeutics
  • limits unwanted reactions with uncapped amino acids, increasing therapeutic stability and efficacy
  • supports the embryonic peptide drug market including the manufacture of various GLP-1 drugs
  • state-of-the-art manufacturing process in Texas, with capabilities to grow with our customer's demands
  • only large-scale manufacturer in North America that can achieve high purity (>99.5%) in one manufacturing process without the need of secondary purification houses         

markets served